We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microgen | LSE:MCGN | London | Ordinary Share | GB00BVVHWX30 | ORD 6 3/7P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 367.50 | 365.00 | 370.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMCGN
RNS Number : 8167Z
Microgen PLC
17 March 2017
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Microgen PLC
2. Reason for the notification
YES
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with a similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify): _______________________
3. Full name of person(s) subject to notification obligation: Aberforth Partners LLP
4. Full name of shareholder(s) (if different from 3): Nortrust Nominees Ltd
5. Date of transaction (and date on which the threshold is crossed or reached if different):
16/03/2017
6. Date on which issuer notified: 17/03/2017
7. Threshold(s) that is/are crossed or reached: 10%
8: Notified Details
A: Voting rights attached to shares
Class/type of shares Situation previous to the triggering transaction Resulting situation after the triggering transaction
If possible use ISIN code Number of shares Number of voting rights Number of shares
Number of voting rights % of voting rights Direct Indirect Direct Indirect
Ordinary 6,041,032 6,041,032 5,485,332 N/A 5,485,332 N/A 9.14
GB00BVVHWX30
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion period
No. of voting rights that may be acquired if the instrument exercised/converted
% of voting rights
N/A N/A N/A N/A N/A
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration price Expiration date Exercise/ conversion period
No. of voting rights instrument refers to % of voting rights Nominal %
N/A N/A N/A N/A N/A N/A N/A
Total (A+B+C)
Number of voting rights Percentage of voting rights
5,485,332 9.14
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:
Held by Aberforth Partners LLP
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information:
14. Contact name: Pauline Robson, Aberforth Partners LLP
15. Contact telephone name: 0131 220 0733
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLSFSFFWFWSEED
(END) Dow Jones Newswires
March 17, 2017 07:22 ET (11:22 GMT)
1 Year Microgen Chart |
1 Month Microgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions